Literature DB >> 24634691

Mortality related to coagulase-negative staphylococcal bacteremia in febrile neutropenia: A cohort study.

Regis G Rosa1, Rodrigo P Dos Santos1, Luciano Z Goldani1.   

Abstract

BACKGROUND: Coagulase-negative staphylococci (CoNS) are currently the most common isolates recovered from the blood of patients with cancer and febrile neutropenia (FN).
OBJECTIVES: To assess the mortality associated with bloodstream infections (BSIs) caused by CoNS in cancer patients with FN.
METHODS: A prospective cohort study was conducted in a single tertiary hospital from October 2009 to August 2011. Follow-ups were performed on all of the adult patients who were admitted to the hematology ward with cancer and FN. Bacteremia caused by CoNS was defined as two positive results of two independent cultures. Twenty-eight days after the onset of FN, the mortality rates of the patients with BSIs caused by CoNS were compared with those of patients with BSIs caused by other pathogens.
RESULTS: A total of 169 subjects were evaluated. During the study period, 78 patients with BSIs were documented. Twenty-three BSIs (29.4%) were a result of CoNS. CoNS-induced bacteremia resulted in lower 28-day mortality compared with bacteremia caused by other pathogens (4.3% versus 32.7%; log-rank P=0.009). In a Cox proportional hazards regression analysis, BSIs caused by CoNS were independently associated with lower mortality (HR 0.09 [95% CI 0.01 to 0.74]).
CONCLUSIONS: In adult patients with cancer and FN, BSIs caused by CoNS were associated with lower mortality compared with BSIs caused by other pathogens.

Entities:  

Keywords:  Bacteremia; Fever; Immunocompromised host; Mortality; Neutropenia; Staphylococcus

Year:  2014        PMID: 24634691      PMCID: PMC3950980          DOI: 10.1155/2014/702621

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  13 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.

Authors:  Reuben Ramphal
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

Review 3.  Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.

Authors:  Mical Paul; Sara Borok; Abigail Fraser; Liat Vidal; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2005-02-18       Impact factor: 5.790

Review 4.  Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia.

Authors:  R N Jones
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

Review 5.  Coagulase-negative staphylococci: pathogens associated with medical progress.

Authors:  M E Rupp; G L Archer
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

6.  The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Authors:  J Klastersky; M Paesmans; E B Rubenstein; M Boyer; L Elting; R Feld; J Gallagher; J Herrstedt; B Rapoport; K Rolston; J Talcott
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

Review 7.  [Etiology of bacterial infections in febrile neutropenic patients: the role of the laboratory in the diagnosis].

Authors:  Claire Poyart; Philippe Morand; Agnès Buzyn
Journal:  Presse Med       Date:  2004-04-10       Impact factor: 1.228

8.  Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients.

Authors:  J Molina; I Peñuela; J A Lepe; A Gutiérrez-Pizarraya; M J Gómez; E García-Cabrera; E Cordero; J Aznar; J Pachón
Journal:  J Infect       Date:  2012-10-26       Impact factor: 6.072

9.  Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.

Authors:  Tariq Butt; Raja Kamran Afzal; Rifat Nadeem Ahmad; Muhammad Salman; Abid Mahmood; Masood Anwar
Journal:  J Ayub Med Coll Abbottabad       Date:  2004 Jan-Mar

10.  Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients. CEMIC (French-Belgian Study Club of Infectious Diseases in Cancer).

Authors:  D Coullioud; P Van der Auwera; M Viot; C Lasset
Journal:  Support Care Cancer       Date:  1993-01       Impact factor: 3.603

View more
  11 in total

1.  Bacteremia During Early Post-allogeneic Hematopoietic Stem Cell Transplantation Period: A Single Center Experience.

Authors:  Amro Mohamed Sedky El-Ghammaz
Journal:  Indian J Hematol Blood Transfus       Date:  2016-06-29       Impact factor: 0.900

Review 2.  Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.

Authors:  Ofrat Beyar-Katz; Yaakov Dickstein; Sara Borok; Liat Vidal; Leonard Leibovici; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2017-06-03

3.  Impact of QuickFISH in addition to antimicrobial stewardship on vancomycin use and resource utilization in cancer patients with coagulase-negative staphylococcal blood cultures.

Authors:  S K Seo; Z Gedrimaite; A Paskovaty; K Seier; S Morjaria; N Cohen; E Riedel; Y W Tang; N E Babady
Journal:  Clin Microbiol Infect       Date:  2018-03-13       Impact factor: 8.067

Review 4.  Bloodstream infections in neutropenic cancer patients: A practical update.

Authors:  Giulia Gustinetti; Malgorzata Mikulska
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

5.  Vancomycin Heteroresistance and Clinical Outcomes in Bloodstream Infections Caused by Coagulase-Negative Staphylococci.

Authors:  Jason W Rosch; Joshua Wolf; Tina H Dao; Ramzi Alsallaq; Joshua B Parsons; Jose Ferrolino; Randall T Hayden; Jeffrey E Rubnitz; Iftekhar M Rafiqullah; D Ashley Robinson; Elisa B Margolis
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

6.  Low rates of antibiotic resistance and infectious mortality in a cohort of high-risk hematology patients: A single center, retrospective analysis of blood stream infection.

Authors:  Jason R Conn; Elizabeth M Catchpoole; Naomi Runnegar; Sally J Mapp; Kate A Markey
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

7.  Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.

Authors:  Koichi Yamada; Hiroki Namikawa; Hiroki Fujimoto; Kiyotaka Nakaie; Etsuko Takizawa; Yasuyo Okada; Akiko Fujita; Hiroyoshi Kawaguchi; Yasutaka Nakamura; Junko Abe; Yukihiro Kaneko; Hiroshi Kakeya
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

8.  Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013-2015.

Authors:  Anne Santerre Henriksen; Jennifer Smart; Kamal Hamed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-06       Impact factor: 3.267

9.  Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years.

Authors:  K Govind Babu; D Lokanatha; K C Lakshmaiah; M C Suresh Babu; Linu A Jacob; Gita R Bhat; Harsha Vardhana; Mahua Sinha; B R Vijaykumar; B G Sumati; R S Jayshree
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Jul-Sep

10. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.